Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)

N/AEnrolling By InvitationNCT05131594

Huntington Memorial Hospital100 enrolled

Overview

Many people who have had COVID 19 continue to experience symptoms long after they have recovered from the acute infection. This study will examine the clinical symptoms of people with "Long COVID" and measure various markers of inflammation in their blood.

Patients who attend the Long Covid Recovery Clinic at Huntington Hospital will be offered participation in the study. After giving written informed consent, their medical history along with a description of clinical symptoms given through an extensive questionnaire will be accessed. Venous blood will be collected as a baseline and then at follow up visits (as dictated by changes in clinical symptomatology) for evaluation of corollary immune parameters. Patients will be followed at a minimum of every 2 months for 2 years.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

COVID-19

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Enrolled in Huntington Hospital\'s Long Covid Recovery Clinic * Documented previous infection with SARS-CoV2 * Symptoms suggestive of post-acute sequelae of SARS-CoV2 (including but not limited to chronic fatigue, brain fog, muscle and joint pain, cardiac and pulmonary issues, or other factors related to their acute COVID-19 event) * Signed Informed Consent Form Exclusion Criteria: * No documented positive SARS-CoV2 serologies * No post-acute sequelae of SARS-CoV2 symptomatology * Incarcerated

Locations (1)

Huntington Hospital

Pasadena, California, United States

Outcomes

Primary Outcomes

Correlation of symptomatology with inflammatory profiles in patients with Post-Acute Sequelae of SARS-CoV2 (PASC)

Do patient symptoms correlate with abnormalities in inflammatory profiles?

Time frame: From onset of infection to 24 months

Identification of immunologic and inflammatory features of PASC based on results of immunologic and inflammatory assays

Are there abnormalities in immunologic and inflammatory assays unique to PASC?

Time frame: From onset of infection to 24 months

Evaluation and delineation of the pathologic pathways and long-term effects of SARS-CoV2 infection

What are the pathological pathways and long-term effects of SARS-CoV2?

Time frame: From onset of infection to 60 months

Identification of risks factor for PASC

What are the risk factors for PASC?

Time frame: From onset of infection to 24 months

Identification of potential sites of therapeutic intervention to ameliorate symptomatology of PASC

Are there potential sites of therapeutic intervention to relieve the symptoms of PASC?

Time frame: From onset of infection to 60 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.